Shuttle Pharmaceuticals Holdings Inc (SHPH)
0.4301
-0.01
(-2.25%)
USD |
NASDAQ |
May 03, 16:00
0.44
+0.01
(+2.30%)
After-Hours: 20:00
Shuttle Pharmaceuticals Holdings Cash from Operations (TTM): -5.581M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -5.581M |
| September 30, 2023 | -5.199M |
| June 30, 2023 | -4.714M |
| March 31, 2023 | -3.424M |
| December 31, 2022 | -2.710M |
| Date | Value |
|---|---|
| September 30, 2022 | -2.166M |
| June 30, 2022 | -1.133M |
| March 31, 2022 | -0.8183M |
| December 31, 2021 | -0.3003M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-5.581M
Minimum
Dec 2023
-0.3003M
Maximum
Dec 2021
-2.894M
Average
-2.710M
Median
Dec 2022
Cash from Operations (TTM) Benchmarks
| Bioxytran Inc | -0.6641M |
| NovaBay Pharmaceuticals Inc | -4.131M |
| Palatin Technologies Inc | -26.54M |
| iBio Inc | -18.89M |
| Theriva Biologics Inc | -19.00M |